Login Register Cart 0
Generic placeholder image

Current Rheumatology Reviews

Editor-in-Chief

ISSN (Print): 1573-3971
ISSN (Online): 1875-6360

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Case Report

A Case Report of NMO Transverse Myelitis

Author(s): Anna Lafian, Tandis Mahani, Mehrnaz Hojjati* and Taraneh Sarlati

Volume 20, Issue 2, 2024

Published on: 09 October, 2023

Page: [208 - 212] Pages: 5

DOI: 10.2174/0115733971261420230919110103

Price: $65

Abstract

Background: Transverse myelitis is considered one of the cardinal features of neuromyelitis optica spectrum disorder (NMOSD), an immune-mediated inflammatory condition of the CNS characterized by severe, immune-mediated demyelination and axonal damage predominantly targeting optic nerves and spinal cord. We describe a case in which a diagnosis of NMOSD was established, associated with West Nile Virus (WNV) infection.

Case Presentation: A healthy 18-year-old female presented with intractable hiccups and rapidly progressing paraparesis. MRI demonstrated T2 edema extending from the medulla to the conus, consistent with longitudinally extensive transverse myelitis. Serum and CSF Aquaporin-4 IgG (AQP4) were both positive with high titers. In conjunction with antiviral therapy, immunomodulatory treatment was initiated using pulse methylprednisolone, plasmapheresis and Rituximab. A month and a half after admission, the patient was fully ambulatory with no residual symptoms. On her rheumatology follow-up visit, West Nile Virus-specific IgM in CSF was found to be positive from the patient’s initial presentation.

Conclusion: We propose that West Nile Virus may have been the autoimmune trigger to the patient’s development of NMOSD, highlighting the importance of evaluating viral triggers in autoimmune diseases.

« Previous Next »
[1]
Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG. The spectrum of neuromyelitis optica. Lancet Neurol 2007; 6(9): 805-15.
[http://dx.doi.org/10.1016/S1474-4422(07)70216-8] [PMID: 17706564]
[2]
Jarius S, Aboul-Enein F, Waters P, et al. Antibody to aquaporin-4 in the long-term course of neuromyelitis optica. Brain 2008; 131(11): 3072-80.
[http://dx.doi.org/10.1093/brain/awn240] [PMID: 18945724]
[3]
Wingerchuk DM, Banwell B, Bennett JL, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 2015; 85(2): 177-89.
[http://dx.doi.org/10.1212/WNL.0000000000001729] [PMID: 26092914]
[4]
Papadopoulos MC, Verkman AS. Aquaporin 4 and neuromyelitis optica. Lancet Neurol 2012; 11(6): 535-44.
[http://dx.doi.org/10.1016/S1474-4422(12)70133-3] [PMID: 22608667]
[5]
Jasiak-Zatonska M, Kalinowska-Lyszczarz A, Michalak S, et al. The immunology of neuromyelitis optica: Current knowledge, clinical implications, controversies and future perspectives. Int J Mol Sci 2016; 17(3): 273.
[http://dx.doi.org/10.3390/ijms17030273]
[6]
Koga M, Takahashi T, Kawai M, Fujihara K, Kanda T. A serological analysis of viral and bacterial infections associated with neuromyelitis optica. J Neurol Sci 2011; 300(1-2): 19-22.
[http://dx.doi.org/10.1016/j.jns.2010.10.013] [PMID: 21056429]
[7]
Salazar R, Cerghet M, Shad A, Markowitz NP. NMO-IgG positive relapsing longitudinally extensive transverse myelitis (LETM) in a seropositive HIV patient. Clin Neurol Neurosurg 2013; 115(9): 1873-5.
[http://dx.doi.org/10.1016/j.clineuro.2013.03.007] [PMID: 23619533]
[8]
Mancera-Páez O, Román GC, Pardo-Turriago R, Rodríguez Y, Anaya JM. Concurrent Guillain-Barré syndrome, transverse myelitis and encephalitis post-Zika: A case report and review of the pathogenic role of multiple arboviral immunity. J Neurol Sci 2018; 395: 47-53.
[http://dx.doi.org/10.1016/j.jns.2018.09.028] [PMID: 30292020]
[9]
Heerlein K, Jarius S, Jacobi C, Rohde S, Storch-Hagenlocher B, Wildemann B. Aquaporin-4 antibody positive longitudinally extensive transverse myelitis following varicella zoster infection. J Neurol Sci 2009; 276(1-2): 184-6.
[http://dx.doi.org/10.1016/j.jns.2008.08.015] [PMID: 18805556]
[10]
Amano H, Miyamoto N, Shimura H, et al. Influenza-associated MOG antibody-positive longitudinally extensive transverse myelitis: A case report. BMC Neurol 2014; 14(1): 224.
[http://dx.doi.org/10.1186/s12883-014-0224-x] [PMID: 25434485]
[11]
Budhram A, Liu Y, Krawczyk M, et al. High-dose corticosteroids for acute cytomegalovirus-associated transverse myelitis in the immunocompetent patient: A case report and systematic review. J Neurovirol 2019; 25(3): 405-9.
[http://dx.doi.org/10.1007/s13365-018-0717-2] [PMID: 30610740]
[12]
Nakamura Y, Nakajima H, Tani H, et al. Anti-MOG antibody-positive ADEM following infectious mononucleosis due to a primary EBV infection: A case report. BMC Neurol 2017; 17(1): 76.
[http://dx.doi.org/10.1186/s12883-017-0858-6] [PMID: 28420330]
[13]
Kalita J, Vibhute A, Kumar M, Misra UK. Myelopathy in West Nile virus encephalitis: Report of a case and review of literature. J Spinal Cord Med 2020; 43(4): 444-8.
[http://dx.doi.org/10.1080/10790268.2018.1507804] [PMID: 30124385]
[14]
Leis AA, Stokic DS. Neuromuscular manifestations of west nile virus infection. Front Neurol 2012; 3: 37.
[http://dx.doi.org/10.3389/fneur.2012.00037] [PMID: 22461779]
[15]
Bai F, Thompson EA, Vig PJS, Leis AA. Current understanding of west nile virus clinical manifestations, immune responses, neuroinvasion, and immunotherapeutic implications. Pathogens 2019; 8(4): 193.
[http://dx.doi.org/10.3390/pathogens8040193] [PMID: 31623175]
[16]
Fujinami RS, von Herrath MG, Christen U, Whitton JL. Molecular mimicry, bystander activation, or viral persistence: Infections and autoimmune disease. Clin Microbiol Rev 2006; 19(1): 80-94.
[http://dx.doi.org/10.1128/CMR.19.1.80-94.2006] [PMID: 16418524]
[17]
Yu SF, Wu HC, Tsai WC, et al. Detecting epstein-barr virus DNA from peripheral blood mononuclear cells in adult patients with systemic lupus erythematosus in Taiwan. Med Microbiol Immunol 2005; 194(3): 115-20.
[http://dx.doi.org/10.1007/s00430-004-0230-5] [PMID: 15378356]
[18]
Moon U, Park S, Oh S, et al. Patients with systemic lupus erythematosus have abnormally elevated Epstein-Barr virus load in blood. Arthritis Res 2004; 6(4): R295-302.
[http://dx.doi.org/10.1186/ar1181] [PMID: 15225364]
[19]
Brown JJ, Jabri B, Dermody TS. A viral trigger for celiac disease. PLoS Pathog 2018; 14(9): e1007181.
[http://dx.doi.org/10.1371/journal.ppat.1007181]
[20]
Smatti MK, Cyprian FS, Nasrallah GK, et al. Viruses and autoimmunity: A review on the potential interaction and molecular mechanisms. Viruses 2019; 11(8): 762.
[http://dx.doi.org/10.3390/v11080762]
[21]
Masuda S, Mori M, Arai K, et al. Epstein-Barr virus persistence and reactivation in neuromyelitis optica. J Neurol Neurosurg Psychiatry 2015; 86(10): 1137-42.
[http://dx.doi.org/10.1136/jnnp-2014-308095] [PMID: 25433035]
[22]
Mathew T, Avati A, D’Souza D, et al. HIV infection associated neuromyelitis optica spectrum disorder: Clinical features, imaging findings, management and outcomes. Mult Scler Relat Disord 2019; 27: 289-93.
[http://dx.doi.org/10.1016/j.msard.2018.11.014] [PMID: 30448469]
[23]
Valiuddin H, Skwirsk B, Paz-Arabo P. Acute transverse myelitis associated with SARS-CoV-2: A Case-Report. Brain, Behavior, & Immunity - Health 2020; 5: 100091.
[http://dx.doi.org/10.1016/j.bbih.2020.100091] [PMID: 32835294]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy